The New York Times
Friday, November 18, 2011 -- 10:46 AM EST
F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
The Food and Drug Administration announced Friday that it was revoking its approval of the drug Avastin for breast cancer after concluding that it "has not been shown to be safe and effective for that use."
Avastin, made by the pharmaceutical company Roche, will remain an approved treatment for certain types of colon, lung, kidney and brain cancer, the F.D.A. commissioner, Margaret A. Hamburg, announced.
Some women who say the drug has been keeping them alive had pleaded desperately for the approval to be retained.
About This E-Mail
You received this message because you are signed up to receive breaking news
alerts from NYTimes.com.
To unsubscribe, change your e-mail address or to sign up for daily headlines
or other newsletters, go to:
620 Eighth Ave.
New York, NY 10018
Copyright 2011 The New York Times Company